Cargando…
Is there a role for vedolizumab in the treatment of ulcerative colitis and Crohn’s disease?
Inflammatory bowel disease (IBD) is an important cause of morbidity and mortality for millions of patients worldwide. Current treatment options include corticosteroids, 5-aminosalicylates, immunosuppressants, and TNFα antagonists. However, these are frequently ineffective in achieving sustained resp...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4038524/ https://www.ncbi.nlm.nih.gov/pubmed/24899819 http://dx.doi.org/10.2147/CEG.S45261 |